HSA
- Marketing authorisation holder: OMEROS CORP
- Status: likely_approved
🇸🇬 Yartemlea in Singapore
Yartemlea (NARSOPLIMAB) regulatory status in Singapore.
Marketing authorisation
Yartemlea in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Singapore
Frequently asked questions
Is Yartemlea approved in Singapore?
Yes. HSA has authorised it.
Who is the marketing authorisation holder for Yartemlea in Singapore?
OMEROS CORP holds the Singaporean marketing authorisation.